In a low-resource setting where injectable uterotonics are unavailable, the WHO-recommended oral drug for treatment of active postpartum hemorrhage is:
- A Misoprostol 800 mcg sublingual ✓
- B Misoprostol 600 mcg oral
- C Misoprostol 400 mcg sublingual
- D Mifepristone 200 mg oral
Correct answer: A. Misoprostol 800 mcg sublingual
Explanation
WHO recommends misoprostol 800 mcg sublingually for treatment of PPH when injectable uterotonics are unavailable. This dose provides rapid absorption via the sublingual route. Misoprostol 600 mcg oral is used for prevention, not treatment. Mifepristone is not used in PPH management.
Reference: WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage, 2012 ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.